Related Experiment Video
Updated: Jun 20, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases
Julien Loubinoux1, Jean-Pierre Bronowicki, Ines A C Pereira
1Laboratoire de Bactériologie-Virologie UMR CNRS 7565, Faculté de Médecine, 54505 Vandoeuvre-lès-Nancy Cedex, France. j.loubinoux@voila.fr
Abstract:
We have searched for sulfate-reducing bacteria in the feces of 41 healthy individuals and 110 patients from a Hepato-Gastro-Enterology Unit using a specific liquid medium (Test-kit Labège, Compagnie Française de Géothermie, Orléans, France). The 110 patients were separated in 22 patients presenting with inflammatory bowel diseases and 88 patients hospitalized for other lower (n=30) or upper (n=58) digestive tract diseases. Sulfate-reducing bacteria were isolated from 10 healthy individuals (24%), 15 patients presenting with inflammatory bowel diseases (68%), and 33 patients with other symptoms (37%). A multiplex PCR was devised for the identification of Desulfovibrio piger (formerly Desulfomonas pigra), Desulfovibrio fairfieldensis and Desulfovibrio desulfuricans, and applied to the above isolates. The strains of sulfate-reducing bacteria consisted of D. piger (39 isolates), D. fairfieldensis (19 isolates) and D. desulfuricans (one isolate). The prevalence of D. piger was significantly higher in inflammatory bowel disease patients (55%) as compared to healthy individuals (12%) or patients with other symptoms (25%) (P<0.05).
Related Concept Videos
Sulfur Assimilation
Dysbiosis of the Gut Microbiota
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Microbes and the Sulfur Cycle
Functions of the Gut Microbiota
Microbiota of the Large Intestine
